Virpax Pharmaceuticals Inc (NQ: VRPX )
0.8072
+0.0745
(+10.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Press Releases about Virpax Pharmaceuticals Inc
![](https://mms.businesswire.com/media/20240813061007/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20240808988879/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20240724073058/en/1691926/22/Logo_01_20_2023.jpg)
Virpax Regains Compliance with Nasdaq Minimum Bid Price
July 24, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240710164147/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20240708446780/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20240529164265/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20240515708006/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20240513956936/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20240429015636/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20240326207993/en/1691926/22/Logo_01_20_2023.jpg)
Virpax Pharmaceuticals Reports 2023 Year-End Results
March 26, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240227925897/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20240227926537/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20240207146325/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20231229571798/en/1691926/22/Logo_01_20_2023.jpg)
Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting
December 29, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231117425697/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20231117868167/en/1691926/22/Logo_01_20_2023.jpg)
Virpax Pharmaceuticals Announces Leadership Transition
November 17, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231115457375/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20231031904726/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20231012470886/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20231002358935/en/1691926/22/Logo_01_20_2023.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230927781607/en/1691926/22/Logo_01_20_2023.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230926850663/en/1691926/22/Logo_01_20_2023.jpg)
Virpax Pharmaceuticals to Present at the LD Micro Main Event XVI
September 26, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230921062012/en/761346/5/Altasciences_Gradient_V_RGB.jpg)
![](https://mms.businesswire.com/media/20230918682706/en/1691926/22/Logo_01_20_2023.jpg)
Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals
September 18, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230905064620/en/1691926/22/Logo_01_20_2023.jpg)
Virpax Pharmaceuticals Updates on Litigation
September 05, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230828154147/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230814071888/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230810169568/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230724118086/en/1691926/22/Logo_01_20_2023.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.